NEWS & EVENTS 
SPECIALTY CARE
ADA 2025 Poster: Enhancing Care Coordination between Endocrinology and Primary Care for Type 2 Diabetes through a Statewide Quality Improvement Collaborative
Updated: 08/29/25
Citation: Iyengar JJ, Mizokami-Stout KR, Ang L, et al. 1075-P: Enhancing Care Coordination between Endocrinology and Primary Care for Type 2 Diabetes through a Statewide Quality Improvement Collaborative. Diabetes. 2025;74(Supplement_1). doi: 10.2337/db25-1075-P
Presented at the American Diabetes Association Scientific Sessions, June 2025, Chicago, Illinois.
Poster Title: Enhancing Care Coordination between Endocrinology and Primary Care for Type 2 Diabetes through a Statewide Quality Improvement Collaborative
DOI: 10.2337/db25-1075-P
Authors: Jennifer J. Iyengar; Kara R. Mizokami-Stout; Lynn Ang; Jacqueline Rau; Jacob Reiss; Larrea A. Young; Julian Weisensel; Kaitlyn Watson; Heidi L. Diez; Lauren Oshman; Rodica Pop-busui
Introduction and Objective: The Michigan Collaborative for Type 2 Diabetes (MCT2D) is a statewide quality improvement (QI) initiative aimed at enhancing type 2 diabetes (T2D) care via increased continuous glucose monitoring (CGM), guideline-directed medical therapy, and low-carbohydrate diets, while promoting coordination and collaboration among primary care, endocrinology, and nephrology members. We assessed baseline care coordination readiness among endocrinology practices newly joining MCT2D, and improved care coordination between established MCT2D endocrinology practices and a partnering primary care practice.
Methods: Five newly joined endocrinology practices completed care coordination assessments. Nineteen continuing endocrinology and partnering primary care practices implemented QI projects addressing care coordination. Project selection occurred by 6/14/2024 with completion of at least one Plan-Do-Study-Act cycle by 11/21/2024.
Results: Of 19 projects, topics included improving referral processes (e.g., wait times, tracking, pre-visit testing, n=8), patient co-management (n=5), increasing CGM utilization (n=4), and discharging stable patients back to primary care (n=2). Among 11 endocrinologists across 5 unique practices completing practice assessments, 10/11 (91%) deemed the majority of T2DM referrals appropriate for specialty care. However, 8/11 (73%) of endocrinologists indicated effective care coordination occurred in fewer than half of their co-managed patients, citing time constraints, electronic medical record compatibility, and communication with out-of-system providers as key barriers.
Conclusion: MCT2D successfully launched joint QI projects between endocrinology and primary care, resulting in targeted improvements in care coordination. Persistent challenges underscore the need for ongoing collaborative efforts to improve outcomes for patients with T2D.
Tags: Research, Created By MCT2D, Endocrinology
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.